BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Quetiapine (Seroquel) readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Quetiapine (Seroquel)\, from ClinicalTria
 ls.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT05480150-9231@assetmemo.bio
DTSTAMP:20261121T005021Z
DTSTART;VALUE=DATE:20261231
DTEND;VALUE=DATE:20270101
SUMMARY:Quetiapine (Seroquel): Phase na readout est. (NCT05480150)
DESCRIPTION:Quetiapine (Seroquel)\, phase na\, Bipolar Disorder.\nStudy: Ch
 inese Longitudinal and Systematic Study of Bioplar Disorder\nEstimated pri
 mary completion: 31 December 2026. This is a ClinicalTrials.gov estimate\,
  not a confirmed readout date\, and it can move.\nDrug page: https://asset
 memo.bio/drug/quetiapine-seroquel#upcoming-events\nRegistry record: https:
 //clinicaltrials.gov/study/NCT05480150
URL:https://assetmemo.bio/drug/quetiapine-seroquel#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT04373317-9231@assetmemo.bio
DTSTAMP:20261121T005021Z
DTSTART;VALUE=DATE:20271024
DTEND;VALUE=DATE:20271025
SUMMARY:Quetiapine (Seroquel): Phase 4 readout est. (NCT04373317)
DESCRIPTION:Quetiapine (Seroquel)\, phase 4.\nStudy: Pimavanserin vs. Queti
 apine for Treatment of Parkinson's Psychosis\nEstimated primary completion
 : 24 October 2027. This is a ClinicalTrials.gov estimate\, not a confirmed
  readout date\, and it can move.\nDrug page: https://assetmemo.bio/drug/qu
 etiapine-seroquel#upcoming-events\nRegistry record: https://clinicaltrials
 .gov/study/NCT04373317
URL:https://assetmemo.bio/drug/quetiapine-seroquel#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT06333990-9231@assetmemo.bio
DTSTAMP:20261121T005021Z
DTSTART;VALUE=DATE:20280630
DTEND;VALUE=DATE:20280701
SUMMARY:Quetiapine (Seroquel): Phase 3 readout est. (NCT06333990)
DESCRIPTION:Quetiapine (Seroquel)\, phase 3.\nStudy: Quetiapine to Reduce P
 ost Concussive Syndrome After Mild Traumatic Brain Injury (mTBI)\nEstimate
 d primary completion: June 2028. This is a ClinicalTrials.gov estimate\, n
 ot a confirmed readout date\, and it can move.\nDrug page: https://assetme
 mo.bio/drug/quetiapine-seroquel#upcoming-events\nRegistry record: https://
 clinicaltrials.gov/study/NCT06333990
URL:https://assetmemo.bio/drug/quetiapine-seroquel#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT05973786-9231@assetmemo.bio
DTSTAMP:20261121T005021Z
DTSTART;VALUE=DATE:20280630
DTEND;VALUE=DATE:20280701
SUMMARY:Quetiapine (Seroquel): Phase 3 readout est. (NCT05973786)
DESCRIPTION:Quetiapine (Seroquel)\, phase 3.\nStudy: The Effect of a Six We
 ek Intensified Pharmacological Treatment for Bipolar Depression Compared t
 o Treatment as Usual in Subjects Who Had a First-time Treatment Failure on
  Their First-line Treatment.\nEstimated primary completion: 30 June 2028. 
 This is a ClinicalTrials.gov estimate\, not a confirmed readout date\, and
  it can move.\nDrug page: https://assetmemo.bio/drug/quetiapine-seroquel#u
 pcoming-events\nRegistry record: https://clinicaltrials.gov/study/NCT05973
 786
URL:https://assetmemo.bio/drug/quetiapine-seroquel#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07760168-9231@assetmemo.bio
DTSTAMP:20261121T005021Z
DTSTART;VALUE=DATE:20280830
DTEND;VALUE=DATE:20280831
SUMMARY:Quetiapine (Seroquel): Phase 3 readout est. (NCT07760168)
DESCRIPTION:Quetiapine (Seroquel)\, phase 3.\nStudy: Study of rTMS in Maint
 enance in Treatment Resistant Depression\nEstimated primary completion: 30
  August 2028. This is a ClinicalTrials.gov estimate\, not a confirmed read
 out date\, and it can move.\nDrug page: https://assetmemo.bio/drug/quetiap
 ine-seroquel#upcoming-events\nRegistry record: https://clinicaltrials.gov/
 study/NCT07760168
URL:https://assetmemo.bio/drug/quetiapine-seroquel#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT06062953-9231@assetmemo.bio
DTSTAMP:20261121T005021Z
DTSTART;VALUE=DATE:20290228
DTEND;VALUE=DATE:20290301
SUMMARY:Quetiapine (Seroquel): Phase 2/3 readout est. (NCT06062953)
DESCRIPTION:Quetiapine (Seroquel)\, phase 2/3.\nStudy: Efficacy of Melatoni
 n\, Low-dose Quetiapine\, or Placebo in Patients With Psychiatric Disorder
 s and Comorbid Insomnia\nEstimated primary completion: 28 February 2029. T
 his is a ClinicalTrials.gov estimate\, not a confirmed readout date\, and 
 it can move.\nDrug page: https://assetmemo.bio/drug/quetiapine-seroquel#up
 coming-events\nRegistry record: https://clinicaltrials.gov/study/NCT060629
 53
URL:https://assetmemo.bio/drug/quetiapine-seroquel#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT06433635-9231@assetmemo.bio
DTSTAMP:20261121T005021Z
DTSTART;VALUE=DATE:20300228
DTEND;VALUE=DATE:20300301
SUMMARY:Quetiapine (Seroquel): Phase 4 readout est. (NCT06433635)
DESCRIPTION:Quetiapine (Seroquel)\, phase 4\, Bipolar Disorder.\nStudy: Seq
 uential Multiple Assignment Randomized Trial for Bipolar Depression\nEstim
 ated primary completion: 28 February 2030. This is a ClinicalTrials.gov es
 timate\, not a confirmed readout date\, and it can move.\nDrug page: https
 ://assetmemo.bio/drug/quetiapine-seroquel#upcoming-events\nRegistry record
 : https://clinicaltrials.gov/study/NCT06433635
URL:https://assetmemo.bio/drug/quetiapine-seroquel#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07152184-9231@assetmemo.bio
DTSTAMP:20261121T005021Z
DTSTART;VALUE=DATE:20320201
DTEND;VALUE=DATE:20320202
SUMMARY:Quetiapine (Seroquel): Phase 2 readout est. (NCT07152184)
DESCRIPTION:Quetiapine (Seroquel)\, phase 2\, Schizophrenia.\nStudy: Study 
 Comparing Antipsychotic Dose Reduction vs. Maintenance Treatment in Patien
 ts With Schizophrenia Spectrum Disorder: a Personalized Medicine Approach\
 nEstimated primary completion: 1 February 2032. This is a ClinicalTrials.g
 ov estimate\, not a confirmed readout date\, and it can move.\nDrug page: 
 https://assetmemo.bio/drug/quetiapine-seroquel#upcoming-events\nRegistry r
 ecord: https://clinicaltrials.gov/study/NCT07152184
URL:https://assetmemo.bio/drug/quetiapine-seroquel#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
